NGOZI ADICHIE ACCUSES EURACARE OF INTERFERING IN PROBE OF SON’S DEATH

NGOZI ADICHIE ACCUSES EURACARE OF INTERFERING IN PROBE OF SON’S DEATH

Award-winning Nigerian Novelist, Chimamanda Ngozi Adichie, has accused Euracare Multi-Specialist Hospital, Victoria Island, Lagos, of negligence and actions she said had stalled investigations into the death of her twin son, Nkanu.

In a post shared on Instagram on Saturday, Adichie alleged that the hospital had involved in behavior aimed at stalling inquiries into the circumstances surrounding her son’s death.

Nkanu, the 21-month-old son of the author, died on January 7, 2026, following a brief illness.

Adichie, who published a letter she said she wrote to the Chairman of the Board of Directors of Euracare Multi-Specialist Hospital, stated that she decided to make the letter public because, according to her, remaining silent was not an option.

The author alleged that the hospital’s Medical Director, Dr Tosin Majekodunmi, initially accepted responsibility for errors made during her son’s treatment.

“The day after Nkanu died, on January 8, the medical director visited our home in Ikoyi and admitted the errors made by the anesthesiologist. He accepted full responsibility. He also said that he would fire the anesthesiologist, Dr Titus Ogundare,” Adichie alleged.

She, however, claimed that the hospital’s position subsequently changed.

Adichie further alleged that the hospital failed to provide the situation reports and medical records it had promised her family, and that the records eventually released were incomplete.

According to her, Majekodunmi told her that the anesthesiologist had administered “too much propofol” to her son.

“On January 6, at Euracare hospital, the Medical Director, Dr Tosin Majekodunmi, whom I considered a friend and trusted as a physician, told me that the anesthesiologist had given my son Nkanu ‘too much propofol.’ Those were his exact words to me after I saw him rushing into the Cath lab where Nkanu was,” Adichie wrote.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *